1. Home
  2. AVTX vs WIMI Comparison

AVTX vs WIMI Comparison

Compare AVTX & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • WIMI
  • Stock Information
  • Founded
  • AVTX 2011
  • WIMI 2015
  • Country
  • AVTX United States
  • WIMI China
  • Employees
  • AVTX N/A
  • WIMI N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • WIMI Computer Software: Prepackaged Software
  • Sector
  • AVTX Health Care
  • WIMI Technology
  • Exchange
  • AVTX Nasdaq
  • WIMI Nasdaq
  • Market Cap
  • AVTX 88.4M
  • WIMI 94.3M
  • IPO Year
  • AVTX 2015
  • WIMI 2020
  • Fundamental
  • Price
  • AVTX $4.41
  • WIMI $4.20
  • Analyst Decision
  • AVTX Strong Buy
  • WIMI
  • Analyst Count
  • AVTX 7
  • WIMI 0
  • Target Price
  • AVTX $34.33
  • WIMI N/A
  • AVG Volume (30 Days)
  • AVTX 69.6K
  • WIMI 7.6M
  • Earning Date
  • AVTX 05-12-2025
  • WIMI 01-01-0001
  • Dividend Yield
  • AVTX N/A
  • WIMI N/A
  • EPS Growth
  • AVTX N/A
  • WIMI N/A
  • EPS
  • AVTX N/A
  • WIMI N/A
  • Revenue
  • AVTX $441,000.00
  • WIMI $84,137,968.00
  • Revenue This Year
  • AVTX N/A
  • WIMI N/A
  • Revenue Next Year
  • AVTX N/A
  • WIMI N/A
  • P/E Ratio
  • AVTX N/A
  • WIMI N/A
  • Revenue Growth
  • AVTX N/A
  • WIMI 19.25
  • 52 Week Low
  • AVTX $4.44
  • WIMI $0.27
  • 52 Week High
  • AVTX $17.49
  • WIMI $2.92
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 29.58
  • WIMI 34.94
  • Support Level
  • AVTX $4.59
  • WIMI $3.82
  • Resistance Level
  • AVTX $5.85
  • WIMI $7.26
  • Average True Range (ATR)
  • AVTX 0.85
  • WIMI 1.50
  • MACD
  • AVTX -0.21
  • WIMI -0.31
  • Stochastic Oscillator
  • AVTX 2.41
  • WIMI 4.82

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings primarily consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

Share on Social Networks: